Skip to main content
. 2016 Jul 22;14:107. doi: 10.1186/s12916-016-0652-0

Fig. 5.

Fig. 5

Plasma immunoglobulin M (IgM) titers in cohorts consisting of patients with hepatitis C or patients with inflammatory bowel disease (IBD). a Total, b anti-P1 IgM titers, and c P1/total IgM ratio in healthy controls and patients with hepatitis C. Relationship between the activity score during IBD and d total IgM, e P1-specific IgM, and f P1/total IgM ratio. Inactive disease was given score 0, mild to moderate disease activity was given a score of 1–2, and severe activity was given a score of 3. Data are expressed in mg/dl or relative light units (RLU)/100 ms and presented as means and standard deviations. *p < 0.05, ***p < 0.001